222 related articles for article (PubMed ID: 11030201)
1. Treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Niigata Research Group of Glomerulonephritis and Nephrotic Syndrome.
Nishi S; Ueno M; Shimada H; Oosawa Y; Iino N; Iguchi S; Karasawa R; In H; Kawashima S; Saito N; Imai N; Saito K; Suzuki S; Arakawa M; Gejyo F
Intern Med; 2000 Oct; 39(10):788-93. PubMed ID: 11030201
[TBL] [Abstract][Full Text] [Related]
2. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
[TBL] [Abstract][Full Text] [Related]
4. Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus-Associated Membranoproliferative Glomerulonephritis.
Schrezenmeier E; Wu K; Halleck F; Liefeldt L; Brakemeier S; Bachmann F; Kron S; Budde K; Duerr M
Am J Transplant; 2017 Mar; 17(3):819-823. PubMed ID: 27778453
[TBL] [Abstract][Full Text] [Related]
5. Membranoproliferative glomerulonephritis and circulating cryoglobulins.
Hiramatsu R; Hoshino J; Suwabe T; Sumida K; Hasegawa E; Yamanouchi M; Hayami N; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
Clin Exp Nephrol; 2014 Feb; 18(1):88-94. PubMed ID: 23722669
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus associated glomerulopathies.
Ozkok A; Yildiz A
World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
[TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment for immune-complex-mediated membranoproliferative glomerulonephritis.
Lu Q; Zuo L; Dong B; Yan Y; Yang B
Immunotherapy; 2018 Sep; 10(12):1027-1031. PubMed ID: 30185139
[TBL] [Abstract][Full Text] [Related]
8. Crescentic glomerulonephritis developing in the course of idiopathic membranoproliferative glomerulonephritis.
Sharma A; Gupta R; Lal C; Agarwal SK; Dinda AK
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):333-7. PubMed ID: 23538361
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy.
Morales JM; Kamar N; Rostaing L
Contrib Nephrol; 2012; 176():10-23. PubMed ID: 22310777
[TBL] [Abstract][Full Text] [Related]
10. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
11. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatitis C-virus-related glomerulonephritis.
Kamar N; Rostaing L; Alric L
Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis of membranoproliferative glomerulonephritis in KwaZulu-Natal, South Africa is unrelated to hepatitis C virus infection.
Madala ND; Naicker S; Singh B; Naidoo M; Smith AN; Rughubar K
Clin Nephrol; 2003 Aug; 60(2):69-73. PubMed ID: 12940606
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
[TBL] [Abstract][Full Text] [Related]
15. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
[TBL] [Abstract][Full Text] [Related]
16. Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked.
Bandi L
Postgrad Med; 2003 Feb; 113(2):73-6, 86. PubMed ID: 12611116
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan.
Yamabe H; Johnson RJ; Gretch DR; Fukushi K; Osawa H; Miyata M; Inuma H; Sasaki T; Kaizuka M; Tamura N
J Am Soc Nephrol; 1995 Aug; 6(2):220-3. PubMed ID: 7579088
[TBL] [Abstract][Full Text] [Related]
18. Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection.
Sarac E; Bastacky S; Johnson JP
Am J Kidney Dis; 1997 Jul; 30(1):113-5. PubMed ID: 9214409
[TBL] [Abstract][Full Text] [Related]
19. Effects of pegylated interferon alpha-2a on hepatitis-C-virus-associated glomerulonephritis.
Sugiura T; Yamada T; Kimpara Y; Fujita N; Goto K; Koyama N
Pediatr Nephrol; 2009 Jan; 24(1):199-202. PubMed ID: 18696119
[TBL] [Abstract][Full Text] [Related]
20. Renal disease in hepatitis C-positive liver transplant recipients.
Kendrick EA; McVicar JP; Kowdley KV; Bronner MP; Emond MJ; Alpers CE; Gretch DR; Carithers RL; Perkins JD; Davis CL
Transplantation; 1997 May; 63(9):1287-93. PubMed ID: 9158023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
